Ivuxolimab, previously known as PF-04518600, represents a new therapeutic approach as a precise PD-1 antagonist of the IgG1 isotype. Studies suggest that this molecule holds significant promise for treating a https://ivuxolimabpf04518600634536.wikicorrespondence.com/user